Home | Business News | CBJ Newsmakers | Helix BioPharma Corp. Closes Private Placement, Extends Period to Exercise Warrants and Provides Corporate Update Helix BioPharma Corp. Closes Private Placement, Extends Period to Exercise Warrants and Provides Corporate Update CBJ Newsmakers RecommendedMicrobix Receives $4.25 Million Order For Viral Transport MediumAppnovation’s Iain MacNeil wins 2021 Report on Business Best Executive AwardGuitars for Vets Cross Country Tour